Global Biomarker POCT Market Growth 2026-2032

October 2026 | 123 pages | ID: GD90CC34FDDCEN
LP Information

Abstracts

The global Biomarker POCT market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Biomarker POCT is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Biomarker POCT is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Biomarker POCT is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Biomarker POCT players cover Roche, Abbott, Siemens Healthineers, Danaher, Assure Tech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Biomarker POCT Industry Forecast” looks at past sales and reviews total world Biomarker POCT sales in 2025, providing a comprehensive analysis by region and market sector of projected Biomarker POCT sales for 2026 through 2032. With Biomarker POCT sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomarker POCT industry.

This Insight Report provides a comprehensive analysis of the global Biomarker POCT landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biomarker POCT portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomarker POCT market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomarker POCT and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomarker POCT.

This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker POCT market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Lateral Immunoassay
• Microfluidics
• Plasma Technique
• Other

Segmentation by Application:

• Pathogen Nucleic Acid
• Antibody
• Pathogen Protein
• Circulating MicroRNA

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Roche
• Abbott
• Siemens Healthineers
• Danaher
• Assure Tech
• BioMerieux
• Bio-Rad Laboratories
• Wondfo
• Wuhan Easy Diagnosis
• Getein Biotech
• Beijing Hotgen Biotech Co.,ltd.
• Beijing Wantai BioPharm
• Zhejiang Orient Gene Biotech Co.,Ltd.
• Sansure Biotech Inc.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Biomarker POCT market?
• What factors are driving Biomarker POCT market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Biomarker POCT market opportunities vary by end market size?
• How does Biomarker POCT break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biomarker POCT Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Biomarker POCT by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Biomarker POCT by Country/Region, 2021, 2025 & 2032
2.2 Biomarker POCT Segment by Type
  2.2.1 Lateral Immunoassay
  2.2.2 Microfluidics
  2.2.3 Plasma Technique
  2.2.4 Other
  2.2.5 Biomarker POCT Sales by Type
    2.2.5.1 Global Biomarker POCT Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Biomarker POCT Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Biomarker POCT Sale Price by Type (2021-2026)
2.3 Biomarker POCT Segment by Application
  2.3.1 Pathogen Nucleic Acid
  2.3.2 Antibody
  2.3.3 Pathogen Protein
  2.3.4 Circulating MicroRNA
  2.3.5 Biomarker POCT Sales by Application
    2.3.5.1 Global Biomarker POCT Sale Market Share by Application (2021-2026)
    2.3.5.2 Global Biomarker POCT Revenue and Market Share by Application (2021-2026)
    2.3.5.3 Global Biomarker POCT Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Biomarker POCT Breakdown Data by Company
  3.1.1 Global Biomarker POCT Annual Sales by Company (2021-2026)
  3.1.2 Global Biomarker POCT Sales Market Share by Company (2021-2026)
3.2 Global Biomarker POCT Annual Revenue by Company (2021-2026)
  3.2.1 Global Biomarker POCT Revenue by Company (2021-2026)
  3.2.2 Global Biomarker POCT Revenue Market Share by Company (2021-2026)
3.3 Global Biomarker POCT Sale Price by Company
3.4 Key Manufacturers Biomarker POCT Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Biomarker POCT Product Location Distribution
  3.4.2 Players Biomarker POCT Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIOMARKER POCT BY GEOGRAPHIC REGION

4.1 World Historic Biomarker POCT Market Size by Geographic Region (2021-2026)
  4.1.1 Global Biomarker POCT Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Biomarker POCT Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biomarker POCT Market Size by Country/Region (2021-2026)
  4.2.1 Global Biomarker POCT Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Biomarker POCT Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biomarker POCT Sales Growth
4.4 APAC Biomarker POCT Sales Growth
4.5 Europe Biomarker POCT Sales Growth
4.6 Middle East & Africa Biomarker POCT Sales Growth

5 AMERICAS

5.1 Americas Biomarker POCT Sales by Country
  5.1.1 Americas Biomarker POCT Sales by Country (2021-2026)
  5.1.2 Americas Biomarker POCT Revenue by Country (2021-2026)
5.2 Americas Biomarker POCT Sales by Type (2021-2026)
5.3 Americas Biomarker POCT Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biomarker POCT Sales by Region
  6.1.1 APAC Biomarker POCT Sales by Region (2021-2026)
  6.1.2 APAC Biomarker POCT Revenue by Region (2021-2026)
6.2 APAC Biomarker POCT Sales by Type (2021-2026)
6.3 APAC Biomarker POCT Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Biomarker POCT by Country
  7.1.1 Europe Biomarker POCT Sales by Country (2021-2026)
  7.1.2 Europe Biomarker POCT Revenue by Country (2021-2026)
7.2 Europe Biomarker POCT Sales by Type (2021-2026)
7.3 Europe Biomarker POCT Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biomarker POCT by Country
  8.1.1 Middle East & Africa Biomarker POCT Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Biomarker POCT Revenue by Country (2021-2026)
8.2 Middle East & Africa Biomarker POCT Sales by Type (2021-2026)
8.3 Middle East & Africa Biomarker POCT Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biomarker POCT
10.3 Manufacturing Process Analysis of Biomarker POCT
10.4 Industry Chain Structure of Biomarker POCT

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Biomarker POCT Distributors
11.3 Biomarker POCT Customer

12 WORLD FORECAST REVIEW FOR BIOMARKER POCT BY GEOGRAPHIC REGION

12.1 Global Biomarker POCT Market Size Forecast by Region
  12.1.1 Global Biomarker POCT Forecast by Region (2027-2032)
  12.1.2 Global Biomarker POCT Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biomarker POCT Forecast by Type (2027-2032)
12.7 Global Biomarker POCT Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Biomarker POCT Product Portfolios and Specifications
  13.1.3 Roche Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments
13.2 Abbott
  13.2.1 Abbott Company Information
  13.2.2 Abbott Biomarker POCT Product Portfolios and Specifications
  13.2.3 Abbott Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Abbott Main Business Overview
  13.2.5 Abbott Latest Developments
13.3 Siemens Healthineers
  13.3.1 Siemens Healthineers Company Information
  13.3.2 Siemens Healthineers Biomarker POCT Product Portfolios and Specifications
  13.3.3 Siemens Healthineers Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Siemens Healthineers Main Business Overview
  13.3.5 Siemens Healthineers Latest Developments
13.4 Danaher
  13.4.1 Danaher Company Information
  13.4.2 Danaher Biomarker POCT Product Portfolios and Specifications
  13.4.3 Danaher Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Danaher Main Business Overview
  13.4.5 Danaher Latest Developments
13.5 Assure Tech
  13.5.1 Assure Tech Company Information
  13.5.2 Assure Tech Biomarker POCT Product Portfolios and Specifications
  13.5.3 Assure Tech Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Assure Tech Main Business Overview
  13.5.5 Assure Tech Latest Developments
13.6 BioMerieux
  13.6.1 BioMerieux Company Information
  13.6.2 BioMerieux Biomarker POCT Product Portfolios and Specifications
  13.6.3 BioMerieux Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 BioMerieux Main Business Overview
  13.6.5 BioMerieux Latest Developments
13.7 Bio-Rad Laboratories
  13.7.1 Bio-Rad Laboratories Company Information
  13.7.2 Bio-Rad Laboratories Biomarker POCT Product Portfolios and Specifications
  13.7.3 Bio-Rad Laboratories Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Bio-Rad Laboratories Main Business Overview
  13.7.5 Bio-Rad Laboratories Latest Developments
13.8 Wondfo
  13.8.1 Wondfo Company Information
  13.8.2 Wondfo Biomarker POCT Product Portfolios and Specifications
  13.8.3 Wondfo Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Wondfo Main Business Overview
  13.8.5 Wondfo Latest Developments
13.9 Wuhan Easy Diagnosis
  13.9.1 Wuhan Easy Diagnosis Company Information
  13.9.2 Wuhan Easy Diagnosis Biomarker POCT Product Portfolios and Specifications
  13.9.3 Wuhan Easy Diagnosis Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Wuhan Easy Diagnosis Main Business Overview
  13.9.5 Wuhan Easy Diagnosis Latest Developments
13.10 Getein Biotech
  13.10.1 Getein Biotech Company Information
  13.10.2 Getein Biotech Biomarker POCT Product Portfolios and Specifications
  13.10.3 Getein Biotech Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Getein Biotech Main Business Overview
  13.10.5 Getein Biotech Latest Developments
13.11 Beijing Hotgen Biotech Co.,ltd.
  13.11.1 Beijing Hotgen Biotech Co.,ltd. Company Information
  13.11.2 Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Product Portfolios and Specifications
  13.11.3 Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Beijing Hotgen Biotech Co.,ltd. Main Business Overview
  13.11.5 Beijing Hotgen Biotech Co.,ltd. Latest Developments
13.12 Beijing Wantai BioPharm
  13.12.1 Beijing Wantai BioPharm Company Information
  13.12.2 Beijing Wantai BioPharm Biomarker POCT Product Portfolios and Specifications
  13.12.3 Beijing Wantai BioPharm Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Beijing Wantai BioPharm Main Business Overview
  13.12.5 Beijing Wantai BioPharm Latest Developments
13.13 Zhejiang Orient Gene Biotech Co.,Ltd.
  13.13.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
  13.13.2 Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Product Portfolios and Specifications
  13.13.3 Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Zhejiang Orient Gene Biotech Co.,Ltd. Main Business Overview
  13.13.5 Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
13.14 Sansure Biotech Inc.
  13.14.1 Sansure Biotech Inc. Company Information
  13.14.2 Sansure Biotech Inc. Biomarker POCT Product Portfolios and Specifications
  13.14.3 Sansure Biotech Inc. Biomarker POCT Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Sansure Biotech Inc. Main Business Overview
  13.14.5 Sansure Biotech Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biomarker POCT Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biomarker POCT Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lateral Immunoassay
Table 4. Major Players of Microfluidics
Table 5. Major Players of Plasma Technique
Table 6. Major Players of Other
Table 7. Global Biomarker POCT Sales by Type (2021-2026) & (K Units)
Table 8. Global Biomarker POCT Sales Market Share by Type (2021-2026)
Table 9. Global Biomarker POCT Revenue by Type (2021-2026) & ($ million)
Table 10. Global Biomarker POCT Revenue Market Share by Type (2021-2026)
Table 11. Global Biomarker POCT Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Biomarker POCT Sale by Application (2021-2026) & (K Units)
Table 13. Global Biomarker POCT Sale Market Share by Application (2021-2026)
Table 14. Global Biomarker POCT Revenue by Application (2021-2026) & ($ million)
Table 15. Global Biomarker POCT Revenue Market Share by Application (2021-2026)
Table 16. Global Biomarker POCT Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Biomarker POCT Sales by Company (2021-2026) & (K Units)
Table 18. Global Biomarker POCT Sales Market Share by Company (2021-2026)
Table 19. Global Biomarker POCT Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Biomarker POCT Revenue Market Share by Company (2021-2026)
Table 21. Global Biomarker POCT Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Biomarker POCT Producing Area Distribution and Sales Area
Table 23. Players Biomarker POCT Products Offered
Table 24. Biomarker POCT Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biomarker POCT Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Biomarker POCT Sales Market Share Geographic Region (2021-2026)
Table 29. Global Biomarker POCT Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Biomarker POCT Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Biomarker POCT Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Biomarker POCT Sales Market Share by Country/Region (2021-2026)
Table 33. Global Biomarker POCT Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Biomarker POCT Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Biomarker POCT Sales by Country (2021-2026) & (K Units)
Table 36. Americas Biomarker POCT Sales Market Share by Country (2021-2026)
Table 37. Americas Biomarker POCT Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Biomarker POCT Sales by Type (2021-2026) & (K Units)
Table 39. Americas Biomarker POCT Sales by Application (2021-2026) & (K Units)
Table 40. APAC Biomarker POCT Sales by Region (2021-2026) & (K Units)
Table 41. APAC Biomarker POCT Sales Market Share by Region (2021-2026)
Table 42. APAC Biomarker POCT Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Biomarker POCT Sales by Type (2021-2026) & (K Units)
Table 44. APAC Biomarker POCT Sales by Application (2021-2026) & (K Units)
Table 45. Europe Biomarker POCT Sales by Country (2021-2026) & (K Units)
Table 46. Europe Biomarker POCT Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Biomarker POCT Sales by Type (2021-2026) & (K Units)
Table 48. Europe Biomarker POCT Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Biomarker POCT Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Biomarker POCT Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Biomarker POCT Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Biomarker POCT Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Biomarker POCT
Table 54. Key Market Challenges & Risks of Biomarker POCT
Table 55. Key Industry Trends of Biomarker POCT
Table 56. Biomarker POCT Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biomarker POCT Distributors List
Table 59. Biomarker POCT Customer List
Table 60. Global Biomarker POCT Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Biomarker POCT Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Biomarker POCT Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Biomarker POCT Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Biomarker POCT Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Biomarker POCT Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Biomarker POCT Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Biomarker POCT Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Biomarker POCT Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Biomarker POCT Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Biomarker POCT Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Biomarker POCT Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Biomarker POCT Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Biomarker POCT Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Roche Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Biomarker POCT Product Portfolios and Specifications
Table 76. Roche Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Abbott Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Biomarker POCT Product Portfolios and Specifications
Table 81. Abbott Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Abbott Main Business
Table 83. Abbott Latest Developments
Table 84. Siemens Healthineers Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 85. Siemens Healthineers Biomarker POCT Product Portfolios and Specifications
Table 86. Siemens Healthineers Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Siemens Healthineers Main Business
Table 88. Siemens Healthineers Latest Developments
Table 89. Danaher Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 90. Danaher Biomarker POCT Product Portfolios and Specifications
Table 91. Danaher Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Danaher Main Business
Table 93. Danaher Latest Developments
Table 94. Assure Tech Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 95. Assure Tech Biomarker POCT Product Portfolios and Specifications
Table 96. Assure Tech Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Assure Tech Main Business
Table 98. Assure Tech Latest Developments
Table 99. BioMerieux Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 100. BioMerieux Biomarker POCT Product Portfolios and Specifications
Table 101. BioMerieux Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. BioMerieux Main Business
Table 103. BioMerieux Latest Developments
Table 104. Bio-Rad Laboratories Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 105. Bio-Rad Laboratories Biomarker POCT Product Portfolios and Specifications
Table 106. Bio-Rad Laboratories Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Bio-Rad Laboratories Main Business
Table 108. Bio-Rad Laboratories Latest Developments
Table 109. Wondfo Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 110. Wondfo Biomarker POCT Product Portfolios and Specifications
Table 111. Wondfo Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Wondfo Main Business
Table 113. Wondfo Latest Developments
Table 114. Wuhan Easy Diagnosis Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 115. Wuhan Easy Diagnosis Biomarker POCT Product Portfolios and Specifications
Table 116. Wuhan Easy Diagnosis Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Wuhan Easy Diagnosis Main Business
Table 118. Wuhan Easy Diagnosis Latest Developments
Table 119. Getein Biotech Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 120. Getein Biotech Biomarker POCT Product Portfolios and Specifications
Table 121. Getein Biotech Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Getein Biotech Main Business
Table 123. Getein Biotech Latest Developments
Table 124. Beijing Hotgen Biotech Co.,ltd. Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Product Portfolios and Specifications
Table 126. Beijing Hotgen Biotech Co.,ltd. Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Beijing Hotgen Biotech Co.,ltd. Main Business
Table 128. Beijing Hotgen Biotech Co.,ltd. Latest Developments
Table 129. Beijing Wantai BioPharm Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 130. Beijing Wantai BioPharm Biomarker POCT Product Portfolios and Specifications
Table 131. Beijing Wantai BioPharm Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Beijing Wantai BioPharm Main Business
Table 133. Beijing Wantai BioPharm Latest Developments
Table 134. Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Product Portfolios and Specifications
Table 136. Zhejiang Orient Gene Biotech Co.,Ltd. Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Zhejiang Orient Gene Biotech Co.,Ltd. Main Business
Table 138. Zhejiang Orient Gene Biotech Co.,Ltd. Latest Developments
Table 139. Sansure Biotech Inc. Basic Information, Biomarker POCT Manufacturing Base, Sales Area and Its Competitors
Table 140. Sansure Biotech Inc. Biomarker POCT Product Portfolios and Specifications
Table 141. Sansure Biotech Inc. Biomarker POCT Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Sansure Biotech Inc. Main Business
Table 143. Sansure Biotech Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Biomarker POCT
Figure 2. Biomarker POCT Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biomarker POCT Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Biomarker POCT Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biomarker POCT Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biomarker POCT Sales Market Share by Country/Region (2025)
Figure 10. Biomarker POCT Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lateral Immunoassay
Figure 12. Product Picture of Microfluidics
Figure 13. Product Picture of Plasma Technique
Figure 14. Product Picture of Other
Figure 15. Global Biomarker POCT Sales Market Share by Type in 2026
Figure 16. Global Biomarker POCT Revenue Market Share by Type (2021-2026)
Figure 17. Biomarker POCT Consumed in Pathogen Nucleic Acid
Figure 18. Global Biomarker POCT Market: Pathogen Nucleic Acid (2021-2026) & (K Units)
Figure 19. Biomarker POCT Consumed in Antibody
Figure 20. Global Biomarker POCT Market: Antibody (2021-2026) & (K Units)
Figure 21. Biomarker POCT Consumed in Pathogen Protein
Figure 22. Global Biomarker POCT Market: Pathogen Protein (2021-2026) & (K Units)
Figure 23. Biomarker POCT Consumed in Circulating MicroRNA
Figure 24. Global Biomarker POCT Market: Circulating MicroRNA (2021-2026) & (K Units)
Figure 25. Global Biomarker POCT Sale Market Share by Application (2025)
Figure 26. Global Biomarker POCT Revenue Market Share by Application in 2026
Figure 27. Biomarker POCT Sales by Company in 2026 (K Units)
Figure 28. Global Biomarker POCT Sales Market Share by Company in 2026
Figure 29. Biomarker POCT Revenue by Company in 2026 ($ millions)
Figure 30. Global Biomarker POCT Revenue Market Share by Company in 2026
Figure 31. Global Biomarker POCT Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Biomarker POCT Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Biomarker POCT Sales 2021-2026 (K Units)
Figure 34. Americas Biomarker POCT Revenue 2021-2026 ($ millions)
Figure 35. APAC Biomarker POCT Sales 2021-2026 (K Units)
Figure 36. APAC Biomarker POCT Revenue 2021-2026 ($ millions)
Figure 37. Europe Biomarker POCT Sales 2021-2026 (K Units)
Figure 38. Europe Biomarker POCT Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Biomarker POCT Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Biomarker POCT Revenue 2021-2026 ($ millions)
Figure 41. Americas Biomarker POCT Sales Market Share by Country in 2026
Figure 42. Americas Biomarker POCT Revenue Market Share by Country (2021-2026)
Figure 43. Americas Biomarker POCT Sales Market Share by Type (2021-2026)
Figure 44. Americas Biomarker POCT Sales Market Share by Application (2021-2026)
Figure 45. United States Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Biomarker POCT Sales Market Share by Region in 2026
Figure 50. APAC Biomarker POCT Revenue Market Share by Region (2021-2026)
Figure 51. APAC Biomarker POCT Sales Market Share by Type (2021-2026)
Figure 52. APAC Biomarker POCT Sales Market Share by Application (2021-2026)
Figure 53. China Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 57. India Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Biomarker POCT Sales Market Share by Country in 2026
Figure 61. Europe Biomarker POCT Revenue Market Share by Country (2021-2026)
Figure 62. Europe Biomarker POCT Sales Market Share by Type (2021-2026)
Figure 63. Europe Biomarker POCT Sales Market Share by Application (2021-2026)
Figure 64. Germany Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 65. France Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Biomarker POCT Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Biomarker POCT Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Biomarker POCT Sales Market Share by Application (2021-2026)
Figure 72. Egypt Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Biomarker POCT Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Biomarker POCT in 2026
Figure 78. Manufacturing Process Analysis of Biomarker POCT
Figure 79. Industry Chain Structure of Biomarker POCT
Figure 80. Channels of Distribution
Figure 81. Global Biomarker POCT Sales Market Forecast by Region (2027-2032)
Figure 82. Global Biomarker POCT Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Biomarker POCT Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Biomarker POCT Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Biomarker POCT Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Biomarker POCT Revenue Market Share Forecast by Application (2027-2032)